Crunching the numbers for APTN... Refresh in a moment for the full analysis.
ADAPTIN BIO, INC. (APTN)
Healthcare
mixed
$0
Updated: 2026-04-13
49
TradeApes Score
hold
Financial Strength
35
Weak
Operating Trend
50
Mixed
Valuation
50
Mixed
Capital Allocation
50
Mixed
Risk
80
Strong
Key Findings
+
High ROIC — above 20%, excellent return on invested capital
−
Weak liquidity — current assets below current liabilities
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Add to Watchlist
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.